Phaseline

Targets › CTRL

CTRL (Chymotrypsin-like protease CTRL-1): drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 2; Gastroenterology.

Open in Phaseline: the race on CTRL, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Healthgen BiotechnologyRecombinant Human Chymotrypsin (OsrhCT)
Serine protease; mucolytic enzyme to improve gastric mucosa visualization
CTRLPhase 2Gastric Mucosal Lesion–

Conditions

Gastric Mucosal Lesion (1)

Modalities

small molecule (1)

Companies

Healthgen Biotechnology (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.